These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 16331349

  • 1. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells.
    Muir CP, Adams MA, Graham CH.
    Breast Cancer Res Treat; 2006 Mar; 96(2):169-76. PubMed ID: 16331349
    [Abstract] [Full Text] [Related]

  • 2. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
    Frederiksen LJ, Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, Adams MA, Bennett BM, Siemens DR, Graham CH.
    Clin Cancer Res; 2007 Apr 01; 13(7):2199-206. PubMed ID: 17404104
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate.
    Frederiksen LJ, Siemens DR, Heaton JP, Maxwell LR, Adams MA, Graham CH.
    J Urol; 2003 Sep 01; 170(3):1003-7. PubMed ID: 12913759
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
    Walker J, Martin C, Callaghan R.
    Eur J Cancer; 2004 Mar 01; 40(4):594-605. PubMed ID: 14962729
    [Abstract] [Full Text] [Related]

  • 5. Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity.
    Fang Y, Sullivan R, Graham CH.
    Exp Cell Res; 2007 Mar 10; 313(5):867-77. PubMed ID: 17289019
    [Abstract] [Full Text] [Related]

  • 6. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb 10; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
    Singh B, Cook KR, Vincent L, Hall CS, Berry JA, Multani AS, Lucci A.
    J Surg Res; 2008 Jun 15; 147(2):240-6. PubMed ID: 18498876
    [Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.
    Bell EN, Tse MY, Frederiksen LJ, Gardhouse A, Pang SC, Graham CH, Siemens DR.
    J Urol; 2007 Feb 15; 177(2):751-6. PubMed ID: 17222675
    [Abstract] [Full Text] [Related]

  • 9. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing.
    Zhang X, Wang W, Yu W, Xie Y, Zhang X, Zhang Y, Ma X.
    Biotechnol Prog; 2005 Feb 15; 21(4):1289-96. PubMed ID: 16080713
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide-mediated regulation of chemosensitivity in cancer cells.
    Matthews NE, Adams MA, Maxwell LR, Gofton TE, Graham CH.
    J Natl Cancer Inst; 2001 Dec 19; 93(24):1879-85. PubMed ID: 11752013
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
    Koehn H, Magan N, Isaacs RJ, Stowell KM.
    Anticancer Drugs; 2007 Apr 19; 18(4):419-25. PubMed ID: 17351394
    [Abstract] [Full Text] [Related]

  • 12. [Experimental study on resistance to cisplatin and taxol in human ovarian cancer SKOV3ip1 multicellular aggregates].
    Chen J, Feng Y, Zhou X.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Aug 19; 36(8):489-92. PubMed ID: 11758187
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C, Vidgen D.
    Cancer Res; 1984 Nov 19; 44(11):5369-75. PubMed ID: 6488191
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S, Singh R, Hernandez E, Wu G, Chaudhuri G.
    Cancer Res; 2007 Jan 01; 67(1):289-99. PubMed ID: 17210710
    [Abstract] [Full Text] [Related]

  • 15. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
    Ravizza R, Gariboldi MB, Molteni R, Monti E.
    Oncol Rep; 2008 Sep 01; 20(3):625-30. PubMed ID: 18695915
    [Abstract] [Full Text] [Related]

  • 16. Differential changes in purine nucleotides after Doxorubicin treatment of human cancer cells in vitro.
    Walenta S, Feigk B, Wachsmuth I, Dunkern T, Degani H, Mueller-Klieser W.
    Int J Oncol; 2002 Aug 01; 21(2):289-96. PubMed ID: 12118323
    [Abstract] [Full Text] [Related]

  • 17. Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.
    Kerbel RS, St Croix B, Florenes VA, Rak J.
    Hum Cell; 1996 Dec 01; 9(4):257-64. PubMed ID: 9183656
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J.
    Cancer Chemother Pharmacol; 2006 Dec 01; 58(6):776-84. PubMed ID: 16532342
    [Abstract] [Full Text] [Related]

  • 19. A mathematical model of doxorubicin penetration through multicellular layers.
    Evans CJ, Phillips RM, Jones PF, Loadman PM, Sleeman BD, Twelves CJ, Smye SW.
    J Theor Biol; 2009 Apr 21; 257(4):598-608. PubMed ID: 19183560
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Apr 21; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.